Singapore approves Pfizer’s Paxlovid pill for COVID-19 treatment in adult patients
SINGAPORE: Pfizer’s Paxlovid has become the first oral tablet approved in Singapore for the treatment of COVID-19 in adult patients who are at risk of severe disease.
Menu
